Medically reviewed by Jurairat J. Molina, MD More than 25% of the U.S. population experiences seasonal allergies, also known ...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adults and adolescents with ...

Spring is finally here, and for many of us that brings the joy of returning to outdoor activities, planning summer vacations, ...